Why Patients Leave: The Role of Stigma and Discrimination in Decisions to Refuse Post-Overdose Treatment

REFERENCES

• Ahmad, F., J. Cisewski, L. Rossen, and P. Sutton. 2024. Provisional drug overdose death counts. Last Modified February 14, 2024. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
   Google Scholar
• Berridge, K. 2007. The debate over dopamine’s role in reward: The case for incentive salience. Psychopharmacology 191 (3):391–431. doi:10.1007/s00213-006-0578-x.
   PubMed Web of Science ®Google Scholar
• Biancarelli, D., K. Biello, E. Childs, M. Drainoni, P. Salhaney, A. Edeza, M. Mimiaga, R. Saitz, and A. Bazzi. 2019. Strategies used by people who inject drugs to avoid stigma in healthcare Settings. Drug and Alcohol Dependence 198 (May):80–6. doi:10.1016/j.drugalcdep.2019.01.037.
   PubMedGoogle Scholar
• Borowski, S. 2012. The origin and popular use of Occam’s razor. https://www.aaas.org/origin-and-popular-use-occams-razor.
   Google Scholar
• Burnette, J., R. Forsyth, S. Desmarais, and C. Hoyt. 2019. Mindsets of addiction: Implications for treatment intentions. Journal of Social and Clinical Psychology 38 (5):367–94. doi:10.1521/jscp.2019.38.5.367.
   Web of Science ®Google Scholar
• Carusone, S., A. Guta, S. Robinson, D. Tan, C. Cooper, B. O’Leary, K. de Prinse, G. Cobb, R. Upshur, and C. Strike. 2019. Maybe if I stop the drugs, then maybe they’d care?’ – Hospital care experiences of people who use drugs. Harm Reduction Journal 16 (1):7. doi:10.1186/s12954-019-0285-7.
   PubMedGoogle Scholar
• Clemency, B. M., W. Eggleston, E. W. Shaw, M. Cheung, N. S. Pokoj, M. A. Manka, D. J. Giordano, L. Serafin, H. Yu, H. A. Lindstrom, et al. 2018. Hospital Observation Upon Reversal (HOUR) with naloxone: A prospective clinical prediction rule validation study. Academic Emergency Medicine 26 (1):7–15. doi:10.1111/acem.13567.
   PubMed Web of Science ®Google Scholar
• Cohen, A., S. Vakharia, J. Netherland, and K. Frederique. 2022. How the war on drugs impacts social determinants of health beyond the criminal legal system. Annals of Medicine 54 (1):2024–38. doi:10.1080/07853890.2022.2100926.
   PubMed Web of Science ®Google Scholar
• Dasgupta, N., M. D. Simkins, and E. Wheeler. 2021. A thousand ways to say “no” to naloxone. doi:10.17615/1vqa-gt51.
   Google Scholar
• D’Onofrio, G., R. P. McCormack, and K. Hawk. 2018. Emergency departments – A 24/7/365 option for combating the opioid crisis. The New England Journal of Medicine 379 (26):2487–90. doi:10.1056/NEJMp1811988.
   PubMed Web of Science ®Google Scholar
• El-Sabawi, T., and J. Carroll. 2021. A model for defunding: An evidence-based statute for behavioral health crisis response. Temple Law Review, 94 (1). https://heinonline.org/HOL/LandingPage?handle=hein.journals/temple94&div=3&id=&page=.
   Google Scholar
• Farkas, A., M. Lynch, R. Westover, J. Giles, N. Siripong, A. Nalatwad, A. Pizon, and C. Martin-Gill. 2019. Pulmonary complications of opioid overdose treated with naloxone. Annals of Emergency Medicine 75 (1):39–48. doi:10.1016/j.annemergmed.2019.04.006.
   PubMed Web of Science ®Google Scholar
• Fraser, S., K. Pienaar, E. Dilkes-Frayne, D. Moore, R. Kokanovic, C. Treloar, and A. Dunlop. 2017. Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis. The International Journal on Drug Policy 44 (June):192–201. doi:10.1016/j.drugpo.2017.02.005.
   PubMedGoogle Scholar
• Hadaway, P., B. Alexander, R. Coambs, and B. Beyerstein. 1979. The effect of housing and gender on preference for morphine-sucrose solutions in rats. Psychopharmacology 66 (1):87–91. doi:10.1007/BF00431995.
   PubMed Web of Science ®Google Scholar
• Hammer, R., M. Dingel, J. Ostergren, B. Partridge, J. McCormick, and B. Koenig. 2013. Addiction: Current criticism of the brain disease paradigm. The American Journal of Bioethics Neuroscience 4 (3):27–32. doi:10.1080/21507740.2013.796328.
   PubMedGoogle Scholar
• Harocopos, A., B. E. Gibson, N. Saha, M. T. McRae, K. See, S. Rivera, and D. A. Chokshi. 2022. First 2 months of operation at first publicly recognized overdose prevention centers in US. JAMA Network Open 5 (7):e2222149. doi:10.1001/jamanetworkopen.2022.22149.
   PubMed Web of Science ®Google Scholar
• Hart, C. 2014. High price: A neuroscientist’s journey of self-discovery that challenges everything you know about drugs and society. New York, NY: Harper Perennial.
   Google Scholar
• Ivsins, A., J. Boyd, L. Beletsky, and R. McNeil. 2020. Tackling the overdose crisis: The role of safe supply. The International Journal on Drug Policy 80:102769. doi:10.1016/j.drugpo.2020.102769.
   PubMed Web of Science ®Google Scholar
• Kalicum, J., E. Nyx, M. C. Kennedy, and T. Kerr. 2024. The impact of an unsanctioned compassion club on non-fatal overdose. The International Journal on Drug Policy 2024:104330. doi:10.1016/j.drugpo.2024.104330.
   Google Scholar
• Kennedy, M. C., M. Karamouzian, and T. Kerr. 2017. Public health and public order outcomes associated with supervised drug consumption facilities: A systematic review. Current HIV/AIDS Reports 14 (5):161–83. doi:10.1007/s11904-017-0363-y.
   PubMed Web of Science ®Google Scholar
• Kerman, N., S. Manoni-Millar, L. Cormier, T. Cahill, and J. Sylvestre. 2020. It’s not just injecting drugs”: Supervised consumption sites and the social determinants of health. Drug and Alcohol Dependence 213:108078. doi:10.1016/j.drugalcdep.2020.108078.
   PubMed Web of Science ®Google Scholar
• Lambdin, B., P. Davidson, E. Browne, L. Suen, L. Wenger, and A. Kral. 2022. Reduced emergency department visits and hospitalisation with use of an unsanctioned safe consumption site for injection drug use in the United States. Journal of General Internal Medicine 37 (15):3853–60. doi:10.1007/s11606-021-07312-4.
   PubMed Web of Science ®Google Scholar
• Larochelle, M., D. Bernson, T. Land, T. Stopka, N. Wang, Z. Xuan, S. Bagley, J. Liebschutz, and A. Walley. 2018. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study. Annals of Internal Medicine 169 (3):137–45. doi:10.7326/M17-3107.
   PubMed Web of Science ®Google Scholar
• Levy, N. 2013. Addiction is not a brain disease (and it matters). Frontiers in Psychiatry 4:24. doi:10.3389/fpsyt.2013.00024.
   PubMed Web of Science ®Google Scholar
• Lewis, M. 2017. Addiction and the brain: Development, not disease. Neuroethics 10 (1):7–18. doi:10.1007/s12152-016-9293-4.
   PubMed Web of Science ®Google Scholar
• Lie, A., H. Hansen, D. Herzberg, A. Mold, M. Jauffret-Roustide, I. Dussauge, S. Roberts, J. Greene, and N. Campbell. 2022. The harms of constructing addiction as a chronic, relapsing brain disease. American Journal of Public Health 112 (S2):S104–S108. doi:10.2105/ajph.2021.306645.
   PubMedGoogle Scholar
• Livingston, J. 2020. Structural stigma in health-care contexts for people with mental health and substance use issues: A literature review. Ottawa: Mental Health Commission of Canada.
   Google Scholar
• Miller, W., V. Westerberg, R. Harris, and J. Tonigan. 1996. What predicts relapse? Prospective testing of antecedent models. Addiction 91 (12s1):S155–S72. doi:10.1111/j.1360-0443.1996.tb02336.x.
   PubMedGoogle Scholar
• Muncan, B., S. Walters, J. Ezell, and D. Ompad. 2020. They look at us like junkies’: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduction Journal 17 (1):53. doi:10.1186/s12954-020-00399-8.
   PubMed Web of Science ®Google Scholar
• “Non-fatal overdoses short report.” 2023. Substance Abuse and Mental Health Services Administration, March 23. https://www.samhsa.gov/data/sites/default/files/reports/rpt39474/Non-Fatal%20Overdoses%20Short%20Report%20Mar22%20Final.pdf.
   Google Scholar
• Nutt, D., A. Lingford-Hughes, D. Erritzoe, and P. Stokes. 2015. The dopamine theory of addiction: 40 years of highs and lows. Nature Reviews. Neuroscience 16 (5):305–12. doi:10.1038/nrn3939.
   PubMed Web of Science ®Google Scholar
• Oudshoorn, A., M. Sangster Bouck, M. McCann, S. Zendo, H. Berman, J. Banninga, M. J. Le Ber, and Z. Zendo. 2021. A critical narrative inquiry to understand the impacts of an overdose prevention site on the lives of site users. Harm Reduction Journal 18 (1). doi:10.1186/s12954-020-00458-0.
   Web of Science ®Google Scholar
• Room, R. 2021. No level has primacy in what is called addiction: “Addiction is a social disease” would be just as tenable. Neuropsychopharmacology 46 (10):1712–1712. doi:10.1038/s41386-021-01015-4.
   PubMed Web of Science ®Google Scholar
• Sanders, R. 2023. A breakthrough for brain imaging. https://www.universityofcalifornia.edu/news/breakthrough-brain-imaging#:∼:text=With%20the%20higher%20spatial%20resolution,who%20is%20one%20of%20the.
   Google Scholar
• Schlag, A. K. 2020. Percentages of problem drug use and their implications for policy making: A review of the literature. Drug Science, Policy and Law 6:205032452090454. doi:10.1177/205032452090454.
   Google Scholar
• Simon, R., R. Snow, and S. Wakeman. 2020. Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Substance Abuse 41 (4):519–25. doi:10.1080/08897077.2019.1671942.
   PubMed Web of Science ®Google Scholar
• Surratt, H., J. Otachi, C. McLouth, and N. Vundi. 2021. Healthcare stigma and HIV risk among rural people who inject drugs. Drug and Alcohol Dependence 226 (September):108878. doi:10.1016/j.drugalcdep.2021.108878.
   PubMedGoogle Scholar
• Thomas, C., M. Stewart, C. Tschampl, K. Sennaar, D. Schwartz, and J. Dey. 2022. Emergency department interventions for opioid use disorder: A synthesis of emerging models. Journal of Substance Abuse Treatment 141 (October):108837. doi:10.1016/j.jsat.2022.108837.
   PubMedGoogle Scholar
• Tiger, R. 2012. Judging addicts: Drug courts and coercion in the justice system. New York, NY: NYU Press.
   Google Scholar
• van Boekel, L., E. Brouwers, J. van Weeghel, and H. Garretsen. 2013. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug and Alcohol Dependence 131 (1–2):23–35. doi:10.1016/j.drugalcdep.2013.02.018.
   PubMed Web of Science ®Google Scholar
• Volkow, N., G. Koob, and A. McLellan. 2016. Neurobiologic advances from the brain disease model of addiction. The New England Journal of Medicine 374 (4):363–71. doi:10.1056/NEJMra1511480.
   PubMed Web of Science ®Google Scholar
• Weisberg, D., F. Keil, J. Goodstein, E. Rawson, and J. Gray. 2008. The seductive allure of neuroscience explanations. Journal of Cognitive Neuroscience 20 (3):470–7. doi:10.1162/jocn.2008.20040.
   PubMed Web of Science ®Google Scholar
• Willman, M., D. Liss, E. Schwarz, and M. Mullins. 2017. Do heroin overdose patients require observation after receiving naloxone? Clinical Toxicology 55 (2):81–7. doi:10.1080/15563650.2016.1253846.
   PubMed Web of Science ®Google Scholar